Prosecution Insights
Prosecution Insights
24 pending office actions • 20 art units • 23 examiners • 0 of 24 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 24 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 24 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (8%) |
| §103 only | 15 (62%) |
| §102 only | 1 (4%) |
| §112 only | 1 (4%) |
| No statute on record | 5 (21%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DABKOWSKI, ERINNE R | 2 | 55.8% | +69.0% |
| SABOUR, GHAZAL | 1 | 28.1% | +28.6% |
| LANE, DANIEL E | 1 | 4.1% | +8.6% |
| MCLEAN, NEIL R | 1 | 79.7% | +10.4% |
| TSUI, YUNG-SHENG M | 1 | 66.0% | +6.7% |
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 59.3% | +73.3% |
| SULLIVAN, CALEEN O | 1 | 88.5% | +11.4% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +24.5% |
| CRUM, MARY ABOU NADER | 1 | 41.5% | +65.0% |
| BUTTICE, AUDREY L | 1 | 45.8% | +21.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18156899 | METHOD FOR STORING DATA AND OPTICAL STORAGE | SULLIVAN, CALEEN O | 8d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17335602 | DIAGNOSTIC BIOMARKERS FOR SHRIMP ALLERGY | JOHANSEN, PETER N. | 110d overdue |
| 18814269 | DETECTION AND FORECASTING OF NEUROCOGNITIVE DECLINE USING FUNCTIONAL NEUROIMAGING AND MACHINE LEARNING | LANE, DANIEL E | 23d overdue |
| 19272962 | NON-INVASIVE DETECTION OF TISSUE ABNORMALITY USING METHYLATION | SABOUR, GHAZAL | 36d |
| 17691815 | NON-INVASIVE DETERMINATION OF TISSUE SOURCE OF CELL-FREE DNA | CLOW, LORI A | 47d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17921788 | COMPOSITION FOR IMPROVING IMMUNITY | CRUM, MARY ABOU NADER | 73d overdue |
| 17247153 | Methods for Inducing Intermittent Fasting and Modulating Autophagy | DABKOWSKI, ERINNE R | 46d overdue |
| 18134770 | CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION | VISHNYAKOVA, ELENA VLADIMIROVNA | 19d overdue |
| 16427593 | Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities | DABKOWSKI, ERINNE R | 19d overdue |
| 18063604 | COMPOSITIONS AND METHODS FOR IMPROVED MESENCHYMAL STEM CELL THERAPY | WHITE, DAWANNA SHAR-DAY | 18d overdue |
| 18156899 | METHOD FOR STORING DATA AND OPTICAL STORAGE | SULLIVAN, CALEEN O | 8d overdue |
| 18344190 | ARTIFICIAL INTELLIGENCE-AIDED CLASSIFICATION SYSTEM FOR ALZHEIMER'S DISEASE SCREENING FROM RETINAL PHOTOGRAPHS | MCLEAN, NEIL R | 3d overdue |
| 18048547 | SITE-SELECTIVE LYSINE ACETYLATION OF HUMAN IMMUNOGLOBULIN G AND IgG-RELATED PRODUCTS FOR IMMUNOTHERAPY | BUTTICE, AUDREY L | 15d |
| Art Unit | Apps |
|---|---|
| 1685 | 2 |
| 1687 | 2 |
| 3791 | 2 |
| 1654 | 2 |
| 1686 | 1 |
| 3715 | 1 |
| 2681 | 1 |
| 1743 | 1 |
| 1691 | 1 |
| 2899 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19272962 | NON-INVASIVE DETECTION OF TISSUE ABNORMALITY USING METHYLATION | SABOUR, GHAZAL | 1686 | Other | Non-Final OA | 36d | Pending | Jul 17, 2025 |
| 18814269 | DETECTION AND FORECASTING OF NEUROCOGNITIVE DECLINE USING FUNCTIONAL NEUROIMAGING AND MACHINE LEARNING | LANE, DANIEL E | 3715 | §102 | Non-Final OA | 23d overdue | Pending | Aug 23, 2024 |
| 18344190 | ARTIFICIAL INTELLIGENCE-AIDED CLASSIFICATION SYSTEM FOR ALZHEIMER'S DISEASE SCREENING FROM RETINAL PHOTOGRAPHS | MCLEAN, NEIL R | 2681 | §103 | Non-Final OA | 3d overdue | Pending | Jun 29, 2023 |
| 18137732 | SEQUENCING ANALYSIS OF CIRCULATING DNA TO DETECT AND MONITOR AUTOIMMUNE DISEASES | TSUI, YUNG-SHENG M | 1743 | Other | Non-Final OA | 15d overdue | Pending | Apr 21, 2023 |
| 18134770 | CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103 | Non-Final OA | 19d overdue | Pending | Apr 14, 2023 |
| 18156899 | METHOD FOR STORING DATA AND OPTICAL STORAGE | SULLIVAN, CALEEN O | 2899 | §103 | Final Rejection | 8d overdue | Pending | Jan 19, 2023 |
| 18063604 | COMPOSITIONS AND METHODS FOR IMPROVED MESENCHYMAL STEM CELL THERAPY | WHITE, DAWANNA SHAR-DAY | 1627 | §103 | Final Rejection | 18d overdue | Pending | Dec 08, 2022 |
| 17921788 | COMPOSITION FOR IMPROVING IMMUNITY | CRUM, MARY ABOU NADER | 1657 | §103 | Final Rejection | 73d overdue | Pending | Oct 27, 2022 |
| 18048547 | SITE-SELECTIVE LYSINE ACETYLATION OF HUMAN IMMUNOGLOBULIN G AND IgG-RELATED PRODUCTS FOR IMMUNOTHERAPY | BUTTICE, AUDREY L | 1647 | §103 | Final Rejection | 15d | Pending | Oct 21, 2022 |
| 17933753 | METHODS AND COMPOSITIONS FOR PROCESSING BOTANICAL MATERIALS | GREENE, CAROLYN LEE | 1681 | §103 | Non-Final OA | 97d overdue | Pending | Sep 20, 2022 |
| 17814911 | LOW-CONCENTRATION ATROPINE FOR MYOPIA PREVENTION (LAMP-2) STUDY | SHOWALTER, ALEXANDER KEITH | 1629 | §112 | Non-Final OA | 56d overdue | Pending | Jul 26, 2022 |
| 17840409 | IDENTIFYING A DE NOVO FETAL MUTATION FROM A MATERNAL BIOLOGICAL SAMPLE | SCHULTZHAUS, JANNA NICOLE | 1685 | Other | Non-Final OA | 7d | Pending | Jun 14, 2022 |
| 17750123 | METHODS FOR ASSESSING TOXICITY OF A COMPOUND | EIX, EMILY FAY | 1653 | §103 | Non-Final OA | 208d overdue | Pending | May 20, 2022 |
| 17742749 | SIZE-BASED GENOMIC ANALYSIS | ELKINS, BLAKE HARRISON | 1687 | Other | Non-Final OA | 10d overdue | Pending | May 12, 2022 |
| 17691815 | NON-INVASIVE DETERMINATION OF TISSUE SOURCE OF CELL-FREE DNA | CLOW, LORI A | 1687 | §101 | Non-Final OA | 47d | Pending | Mar 10, 2022 |
| 17533991 | HYDROGEL-BASED 3D CELL TRAINING BIOREACTOR | HURST, JONATHAN M | 1799 | §103 | Non-Final OA | 8d overdue | Pending | Nov 23, 2021 |
| 17610124 | EXTRACELLULAR MATRIX MATERIAL AND USES THEREOF | TRAN, KHOA NHAT | 1632 | §103 | Non-Final OA | 6d | Pending | Nov 09, 2021 |
| 17441922 | SUMO PEPTIDES FOR TREATING NEURODEGENERATIVE DISEASES | FISCHER, JOSEPH | 1658 | §103 | Final Rejection | 45d overdue | Pending | Sep 22, 2021 |
| 17335602 | DIAGNOSTIC BIOMARKERS FOR SHRIMP ALLERGY | JOHANSEN, PETER N. | 1644 | §101 | Final Rejection | 110d overdue | Pending | Jun 01, 2021 |
| 17151081 | FLEXIBLE SURGICAL INSTRUMENTS FOR PERCUTANEOUS AND NEUROSURGICAL APPLICATIONS | CERIONI, DANIEL LEE | 3791 | §103 | Final Rejection | 23d overdue | Pending | Jan 15, 2021 |
| 17247153 | Methods for Inducing Intermittent Fasting and Modulating Autophagy | DABKOWSKI, ERINNE R | 1654 | Other | Non-Final OA | 46d overdue | Pending | Dec 02, 2020 |
| 16949581 | METHOD FOR RECOGNIZING A MOTION PATTERN OF A LIMB | LOPEZ, SEVERO ANTON P | 3791 | §103 | Non-Final OA | 51d overdue | Pending | Nov 04, 2020 |
| 16903231 | CANCER SCREENING USING METHYLATION OF CPG ISLANDS | ROSSI, VY BUI | 1685 | §103 | Final Rejection | 113d overdue | Pending | Jun 16, 2020 |
| 16427593 | Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and Comorbidities | DABKOWSKI, ERINNE R | 1654 | §103 | Non-Final OA | 19d overdue | Pending | May 31, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial